A citation-based method for searching scientific literature

Philip J Mease, Iain B McInnes, Bruce Kirkham, Arthur Kavanaugh, Proton Rahman, Désirée van der Heijde, Robert Landewé, Peter Nash, Luminita Pricop, Jiacheng Yuan, Hanno B Richards, Shephard Mpofu. N Engl J Med 2015
Times Cited: 486



Iain B McInnes, Philip J Mease, Bruce Kirkham, Arthur Kavanaugh, Christopher T Ritchlin, Proton Rahman, Désirée van der Heijde, Robert Landewé, Philip G Conaghan, Alice B Gottlieb, Hanno Richards, Luminita Pricop, Gregory Ligozio, Manmath Patekar, Shephard Mpofu. Lancet 2015
Times Cited: 526




List of shared articles



Times cited

Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials.
Alice B Gottlieb, Jashin J Wu, Christopher E M Griffiths, Kwaku Marfo, Elisa Muscianisi, Xiangyi Meng, Jennifer Frueh, Mark Lebwohl. J Dermatolog Treat 2022
3

Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries.
Brigitte Michelsen, Stylianos Georgiadis, Daniela Di Giuseppe, Anne G Loft, Michael J Nissen, Florenzo Iannone, Manuel Pombo-Suarez, Herman Mann, Ziga Rotar, Kari K Eklund,[...]. Arthritis Care Res (Hoboken) 2022
6

Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety.
Frank Kolbinger, Franco Di Padova, Atul Deodhar, Jason E Hawkes, Christine Huppertz, Torsten Kuiper, Iain B McInnes, Christopher T Ritchlin, David Rosmarin, Georg Schett,[...]. Pharmacol Ther 2022
4

Placebo response in psoriatic arthritis clinical trials: a systematic review and meta-analysis.
Gian Luca Erre, Dimitris Mavridis, Richard John Woodman, Arduino Aleksander Mangoni. Rheumatology (Oxford) 2022
0

New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL study.
Jean-Guillaume Letarouilly, Thao Pham, Adeline Pierache, Émilie Acquacalda, Béatrice Banneville, Sébastien Barbarot, Pauline Baudart, Élodie Bauer, Pascal Claudepierre, Arnaud Constantin,[...]. Rheumatology (Oxford) 2022
1

Immunosuppression in Rheumatologic and Auto-immune Disease.
Arundathi Jayatilleke. Handb Exp Pharmacol 2022
0

Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab.
Juan José Lerma Garrido, Antonio Gracia Pérez, Antonio Pérez Torres, Amalia Rueda Cid, Clara Molina Almela, María Dolores Pastor Cubillo, Cristina Campos Fernández, Isabel Balaguer Trull, Loreto Carmona, Javier Calvo Catalá. Reumatol Clin (Engl Ed) 2022
0

Systematic review of the use of CRP in clinical trials for psoriatic arthritis: a concern for clinical practice?
Charlotte Houttekiet, Kurt de Vlam, Barbara Neerinckx, Rik Lories. RMD Open 2022
1

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data.
Alice B Gottlieb, Atul Deodhar, Iain B Mcinnes, Xenofon Baraliakos, Kristian Reich, Stefan Schreiber, Weibin Bao, Kwaku Marfo, Hanno B Richards, Luminita Pricop,[...]. Acta Derm Venereol 2022
2

Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes.
Iain B McInnes, Laura M Sawyer, Kristen Markus, Corinne LeReun, Celia Sabry-Grant, Philip S Helliwell. RMD Open 2022
2

0

Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study.
Tien Nguyen, Melvin Churchill, Robert Levin, Guillermo Valenzuela, Joseph F Merola, Alexis Ogdie, Ana-Maria Orbai, Jose U Scher, Arthur Kavanaugh, Farid Kianifard,[...]. J Rheumatol 2022
0

Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature.
Mika Yamanaka-Takaichi, Soha Ghanian, David A Katzka, Rochelle R Torgerson, Afsaneh Alavi. Am J Clin Dermatol 2022
0

Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry.
Manuel José Moreno-Ramos, Carlos Sanchez-Piedra, Olga Martínez-González, Carlos Rodríguez-Lozano, Carolina Pérez-Garcia, Mercedes Freire, Cristina Campos, Rafael Cáliz-Caliz, Jerusalem Calvo, Juan María Blanco-Madrigal,[...]. Rheumatol Ther 2022
1

Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System.
Yamin Shu, Yufeng Ding, Yanxin Liu, Pan Wu, Xucheng He, Qilin Zhang. Front Pharmacol 2022
0

Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms.
Hoi Ki Joshua Tam, Philip C Robinson, Peter Nash. Curr Rheumatol Rep 2022
0

Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial.
Hermine I Brunner, Ivan Foeldvari, Ekaterina Alexeeva, Nuray Aktay Ayaz, Inmaculada Calvo Penades, Ozgur Kasapcopur, Vyacheslav G Chasnyk, Markus Hufnagel, Zbigniew Żuber, Grant Schulert,[...]. Ann Rheum Dis 2022
0

Exceptional response of skin symptoms to secukinumab treatment in a patient with SAPHO syndrome: Case report and literature review.
Qiang Ji, Qing Wang, Wenping Pan, Yanfeng Hou, Xiuhua Wang, Lin Bian, Zhankui Wang. Medicine (Baltimore) 2022
0

Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study.
Delia Colombo, Micol Frassi, Giusy Pagano Mariano, Enrico Fusaro, Claudia Lomater, Patrizia Del Medico, Florenzo Iannone, Rosario Foti, Massimiliano Limonta, Antonio Marchesoni,[...]. BMC Rheumatol 2022
0

Secukinumab as Biological Treatment for Psoriatic Arthritis in Real Clinical Practice.
José A Pinto Tasende, Francisco J Maceiras Pan, José A Mosquera Martínez, Luis Fernández Dominguez, Blanca Correa Rey, Carlos García Porrúa. Reumatol Clin (Engl Ed) 2021
5

Secukinumab Efficacy in Psoriatic Arthritis: Machine Learning and Meta-analysis of Four Phase 3 Trials.
Alice B Gottlieb, Philip J Mease, Bruce Kirkham, Peter Nash, Alejandro C Balsa, Bernard Combe, Jürgen Rech, Xuan Zhu, David James, Ruvie Martin,[...]. J Clin Rheumatol 2021
8


Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials.
Philip J Mease, Philip S Helliwell, Kasper Fjellhaugen Hjuler, Kyle Raymond, Iain McInnes. Ann Rheum Dis 2021
31


A review of secukinumab in psoriasis treatment.
Scott H Berg, Esther A Balogh, Rima I Ghamrawi, Steven R Feldman. Immunotherapy 2021
5

Safety of secukinumab for the treatment of active ankylosing spondylitis.
Javier Loricera, Eva Galíndez-Aguirregoikoa, Ricardo Blanco. Expert Opin Drug Saf 2021
3

Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers.
Solveig Skovlund Groen, Dovile Sinkeviciute, Anne-Christine Bay-Jensen, Christian S Thudium, Morten A Karsdal, Simon Francis Thomsen, Georg Schett, Signe Holm Nielsen. Autoimmun Rev 2021
3

Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities.
Alan Menter, Gerald G Krueger, So Yeon Paek, Dario Kivelevitch, Iannis E Adamopoulos, Richard G Langley. Dermatol Ther (Heidelb) 2021
7

A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains.
Tiago Torres, Anabela Barcelos, Paulo Filipe, João Eurico Fonseca. Front Med (Lausanne) 2021
5

Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study.
Roberta Ramonda, Mariagrazia Lorenzin, Antonio Carriero, Maria Sole Chimenti, Raffaele Scarpa, Antonio Marchesoni, Ennio Lubrano di Scorpaniello, Carlo Salvarani, Alberto Cauli, Angelo Semeraro,[...]. RMD Open 2021
13

Interleukin-17A Interweaves the Skeletal and Immune Systems.
Mengjia Tang, Lingyun Lu, Xijie Yu. Front Immunol 2021
15



Management of particular clinical situations in psoriatic arthritis: an expert's recommendation document based on systematic literature review and extended Delphi process.
Rosario García-Vicuña, Noemí Garrido, Susana Gómez, Beatriz Joven, Rubén Queiro, Julio Ramírez, Francisco Rebollo, Estíbaliz Loza, Agustí Sellas. Rheumatol Int 2021
1

JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: a critical review of clinical trials.
Stephanie Keeling, Walter P Maksymowych. Expert Rev Clin Immunol 2021
4

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study.
Philip J Mease, Saima Chohan, Ferran J Garcia Fructuoso, Michael E Luggen, Proton Rahman, Siba P Raychaudhuri, Richard C Chou, Alan M Mendelsohn, Stephen J Rozzo, Alice Gottlieb. Ann Rheum Dis 2021
10


Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI).
Anne Tournadre, Jérémie Sellam, Jacques Morel, Denis Jullien, Yoram Bouhnik, Divi Cornec, Valérie Devauchelle-Pensec, Philippe Goupille, Nicolas Kluger, Estibaliz Lazaro,[...]. Joint Bone Spine 2021
0

Targeting the CCR6/CCL20 Axis in Entheseal and Cutaneous Inflammation.
Zhenrui Shi, Emma Garcia-Melchor, Xuesong Wu, Anthony E Getschman, Mimi Nguyen, Douglas J Rowland, Machelle Wilson, Flavia Sunzini, Moeed Akbar, Mindy Huynh,[...]. Arthritis Rheumatol 2021
2

The heterogeneous human memory CCR6+ T helper-17 populations differ in T-bet and cytokine expression but all activate synovial fibroblasts in an IFNγ-independent manner.
Wendy Dankers, Hannah den Braanker, Sandra M J Paulissen, Jan Piet van Hamburg, Nadine Davelaar, Edgar M Colin, Erik Lubberts. Arthritis Res Ther 2021
9

Atypical oral candidiasis in a psoriatic patient during targeted immunotherapy with an interleukin 17 inhibitor (secukinumab).
Bruna Lavinas Sayed Picciani, Arkadiusz Dziedzic, Juliana Tristão Werneck, Marcello Alves Marinho, Thaylla Núñez Amin Dick, Nara Regina Quintanilha, Eliane Pedra Dias. BMC Oral Health 2021
2

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study.
Sara Alonso, Ignacio Villa, Sabela Fernández, José L Martín, Lilyan Charca, Marina Pino, Leyre Riancho, Isla Morante, Monserrat Santos, Anahy Brandy,[...]. Front Med (Lausanne) 2021
8

Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis.
Angela Ceribelli, Francesca Motta, Matteo Vecellio, Natasa Isailovic, Francesco Ciccia, Carlo Selmi. Front Immunol 2021
6

Distinct roles of interleukin-17 and T helper 17 cells among autoimmune diseases.
Shintaro Akiyama, Atsushi Sakuraba. J Transl Autoimmun 2021
6

From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis.
Ettore Silvagni, Sonia Missiroli, Mariasole Perrone, Simone Patergnani, Caterina Boncompagni, Alessandra Bortoluzzi, Marcello Govoni, Carlotta Giorgi, Stefano Alivernini, Paolo Pinton,[...]. Front Pharmacol 2021
3

Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 Studies.
Ana-Maria Orbai, M Elaine Husni, Dafna D Gladman, Ying Ying Leung, Stefan Siebert, William Tillett, Marijn Vis, Olivier Chambenoit, Xiangyi Meng, Philip J Mease. Rheumatol Ther 2021
2

Interleukin-17 inhibitor, is it safer than tumor necrosis factor inhibitor?
Jinxian Huang, Lijun Zhang, James C-C Wei. Int J Rheum Dis 2021
0

Real world effectiveness and satisfaction with secukinumab in the treatment of patients with psoriatic arthritis: a population survey in five European countries.
Philip G Conaghan, Dorothy L Keininger, Elizabeth A Holdsworth, Nicola Booth, Niraj N Modi, Haijun Tian, Uta Kiltz. Curr Med Res Opin 2021
0

Targeted Therapies in Axial Psoriatic Arthritis.
Alberto Floris, Mattia Congia, Elisabetta Chessa, Maria Maddalena Angioni, Matteo Piga, Alberto Cauli. Front Genet 2021
0

Factors Associated with Health-Related Quality of Life in Psoriatic Arthritis Patients: A Longitudinal Analysis.
Dalifer Freites Nuñez, Alfredo Madrid-García, Leticia Leon, Gloria Candelas, Mercedes Núñez, Natalia Bello, Silvia Díaz, Benjamín Fernández-Gutiérrez, Lydia Abasolo, Luis Rodriguez-Rodriguez. Rheumatol Ther 2021
1